Publications of U. Renner

Sauer, J.; Renner, U.; Hopfner, U.; Lange, M.; Strasburger, C.; Pagotto, U.; Müller, A.; Arzt, E.; Stalla, G. K.: Interleukin-1ß enhances interleukin-1 receptor antagonist content in human somatotroph adenoma cell cultures. Journal of Clinical Endocrinology & Metabolism 83, pp. 2429 - 2434 (1998)

Skutella, T.; Probst, J. C.; Renner, U.; Holsboer, F.; Behl, C.: Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety. Neuroscience 85, pp. 795 - 805 (1998)

Skutella, T.; Probst, J. C.; Renner, U.; Holsboer, F.; Behl, C.: Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety. Neuroscience 85, pp. 795 - 805 (1998)

Renner, U.; Pagotto, U.; Arzt, E.; Stalla, G. K.: Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: a review. European Journal of Endocrinology 135, pp. 512 - 532 (1996)

Renner, U.; Stalla, G. K.: Pathogenese von Hypophysenadenomen. Onkologie 19, pp. 340 - 352 (1996)

Arzt, E.; Sauer, J.; Buric, R.; Stalla, J.; Renner, U.; Stalla, G. K.: Characterization and interleukin-2 (IL-2) receptor expression and action of IL-2 and IL-6 on normal anterior pituitary cell growth. Endocrine Journal 2, pp. 269 - 280 (1995)

Pagotto, U.; Arzberger, T.; Hopfner, U.; Sauer, J.; Renner, U.; Newton, C. J.; Lange, M.; Uhl, E.; Weindl, A.; Stalla, G. K.: Expression and localization of endothelin-1 and endothelin-receptors in human meningeomas: Evidence for a role in tumoral growth. Journal of Clinical Investigation 96, pp. 2017 - 2025 (1995)

Renner, U.; Newton, C. J.; Pagotto, U.; Sauer, J.; Arzt, E.; Stalla, G. K.: Involvement of interleukin-1 and interleukin-1 receptor antagonist in rat pituitary cell growth regulation. Endocrinology 136, pp. 3186 - 3193 (1995)

Newton, C. J.; Trapp, T.; Pagotto, U.; Renner, U.; Stalla, G. K.: The oestrogen receptor (ER) modulates growth of pituitary tumor cells in the absence of exogenous oestrogen. Journal of Molecular Endocrinology 12, pp. 303 - 312 (1994)

Renner, U.; Brockmeier, S.; Strasburger, C. J.; Lange, M.; Schopohl, J.; Müller, O. A.; Werder, K. v.; Stalla, G. K.: Growth hormone (GH)-releassing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide. Journal of Clinical Endocrinology and Metabolism 78, pp. 1090 - 1096 (1994)

Renner, U.; Mojito, J.; Lange, M.; Werder, K. v.; Müller, O. A.; Stalla, G. K.: Effect of bromocriptine and SMS 201-995 on growth of human somatotrophic and nonfunctioning pituitary adenoma cells in vitro. European Journal of Endocrinology 130, pp. 80 - 91 (1994)

Stalla, G. K.; Brockmeier, S. J.; Renner, U.; Newton, C.; Buchfelder, M.; Stalla, J.; Müller, O. A.: SMS 201-995 exerts different effects in vivo and in vitro in ACTH dependent Cushing`s syndrome. European Journal of Endocrinology 130, pp. 125 - 131 (1994)

Arzt, E.; Buric, R.; Stelzer, G.; Stalla, J.; Sauer, J.; Renner, U.; Stalla, G. K.: Interleukin involvement in anterior pituitary cell growth regulation: effects of interleukin-2 and interleukin-6. Endocrinology 132, pp. 459 - 467 (1993)

Auernhammer, C.; Renner, U.; Müller, O. A.; Stalla, G. K.: Loperamide inhibits corticotrophic cell function by a naloxone-insensitive mechanism in the rat in vitro. Neuroendocrinology 57, pp. 1019 - 1027 (1993)

Renner, U.; Mojto, J.; Arzt, E.; Lange, M.; Stalla, J.; Müller, O. A.; Stalla, G. K.: Polypeptide growth factors are secreted by human nonfunctioning pituitary adenoma cells in culture. Neuroendocrinology 57, pp. 825 - 834 (1993)

Arzt, E.; Stelzer, G.; Renner, U.; Lange, M.; Müller, O. A.; Stalla, G. K.: Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures. Journal of Clinical Investigation 90, pp. 1944 - 1951 (1992)

Theodoropoulou, M.; Labeur, M.; Paez-Pereda, M.; Haedo, M.; Perone, M. J.; Renner, U.; Arzt, E.; Stalla, G. K.: Novel Medical Therapies for Pituitary Tumors. In: Pituitary Today II: New Molecular, Physiological and Clinical Aspects, pp. 158 - 164 (Eds. Arzt, E.; Bronstein, M.; Guitelman, M.). Karger, Basel (2010)

Renner, U.; De Santana, E. C.; Gerez, J.; Fröhlich, B.; Haedo, M.; Paez-Pereda, M.; Onofri, C.; Stalla, G. K.; Arzt, E.: Intrapituitary Expression and Regulation of the gp130 Cytokine Interleukin-6 and Its Implication in Pituitary Physiology and Pathophysiology. In: Neuroimmunomodulation: from fundamental biology to therapy, pp. 89 - 97 (Ed. Savino, W.). Blackwell, Boston, Mass. (2009)

Giacomini, D.; Páez-Pereda, M.; Theodoropoulou, M.; Gerez, J.; Nagashima, A. C.; Chervin, A.; Berner, S.; Labeur, M.; Refojo, D.; Renner, U. et al.; Stalla, G. K.; Arzt, E.: Bone morphogenetic protein-4 control of pituitary pathophysiology. In: PITUITARY TODAY: MOLECULAR, PHYSIOLOGICAL AND CLINICAL ASPECTS, pp. 22 - 31 (Eds. Arzt, E.; Bronstein, M.; Guitelman, M.). KARGER, BASEL (2006)

Renner, U.; Paez-Pereda, M.; Arzt, E.; Stalla, G. K.: Growth Factors and Cytokine: Function and Molecular Regulation in Pituitary Adenomas. In: Molecular Pathology of the Pituitary, pp. 96 - 109 (Eds. Kontogeorgos, G.; Kovacs, K.). Karger, Basel (2004)